What is the current stock price of Cardiff Lexington Corporation (CDIX)?

As of the latest market data, Cardiff Lexington Corporation (CDIX) is trading at $4.02. The stock has seen a loss of -9.76% today.

Does Cardiff Lexington Corporation (CDIX) pay a dividend?

Based on current data, Cardiff Lexington Corporation does not have a confirmed active dividend policy.

What is the market cap of Cardiff Lexington Corporation?

The current market capitalization of Cardiff Lexington Corporation (CDIX) is approximately unavailable.

CDIX

Cardiff Lexington Corporation·Financial Services

4.02

9.759%(−0.43)

Close Price

Last Updated: — ET

52W L: $1.3052W H: $14.25

CDIX NEWS

accessnewswire.com

May 20

Cardiff Lexington's Nova Ortho and Spine Announces New Medical Office in Stuart, Florida to Serve the Growing Treasure Coast Community

LEXINGTON, KY / ACCESS Newswire / May 20, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) ("Cardiff Lexington" or the "Company"), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that Nova Ortho and Spine, a wholly owned subsidiary of Cardiff Lexington Corporation, has opened a new location in Stuart, Florida. This new location further strengthens Nova Ortho and Spine's expanding regional network of healthcare facilities throughout Florida and supports the organization's broader strategy of increasing accessibility to specialized orthopedic and spine services in underserved and high-growth markets.

accessnewswire.com

May 19

Cardiff Lexington Announces First Quarter 2026 Financial Results

LEXINGTON, KY / ACCESS Newswire / May 19, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) today announced financial results for the first quarter ended March 31, 2026. Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "We continue to strengthen and expand our network of Nova Ortho and Spine locations to support growing patient demand with a focus on more high value procedures, and we remain confident in our ability to build a scalable platform through organic growth and acquisitions that deliver exceptional outcomes for patients.

accessnewswire.com

May 14

Cardiff Lexington to Report First Quarter 2026 Financial Results and Host Conference Call on Tuesday, May 19, 2026

LEXINGTON, KY / ACCESS Newswire / May 14, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that the Company will host an investor conference call to discuss its financial and operating results for the first quarter ended March 31, 2026, on Tuesday, May 19, 2026, at 11:00 am ET. The Company will release its financial and operating results for the first quarter ended March 31, 2026, prior to the call on Tuesday, May 19, 2026.

accessnewswire.com

Apr 9

Cardiff Lexington Corporation Announces Upgrade to OTCQX Best Market

LEXINGTON, KY / ACCESS Newswire / April 9, 2026 / Cardiff Lexington Corporation (OTCQX:CDIX) ("Cardiff Lexington" or the "Company"), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms, today announced that its common stock has been approved to trade on the OTCQX® Best Market, the highest-level market of the OTC Markets, effective at the commencement of trading on Thursday, April 9th, 2026. The Company will continue to trade under the symbol "CDIX".

globenewswire.com

Apr 9

OTC Markets Group Welcomes Cardiff Lexington Corporation to OTCQX

NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cardiff Lexington Corporation (OTCQX: CDIX), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms , has qualified to trade on the OTCQX® Best Market. Cardiff Lexington Corporation upgraded to OTCQX from the OTCQB® Venture Market.

accessnewswire.com

Mar 16

Cardiff Lexington Announces Fourth Quarter and Full Year 2025 Financial Results

39.5% increase in FY25 total revenue to $11.5 million compared to FY 2024 62.7% increase in FY25 gross profit to $7.2 million compared to FY 2024 $1.1 million in income from continuing operations in FY 2025 Strengthening operational team and capital structure to position Company for next phase of growth LEXINGTON, KY / ACCESS Newswire / March 16, 2026 / Cardiff Lexington Corporation (OTCQB:CDIX) today announced financial results for the fourth quarter and full year ended December 31, 2025. Alex Cunningham, Chief Executive Officer of Cardiff Lexington, commented, "2025 was a year of strong strategic execution as we continued to enhance our Nova Ortho and Spine footprint and offerings while making meaningful progress on our long-term goals.

Company Profile

Cardiff Lexington Corporation, together with its subsidiaries, provides affordable housing and tax resolution services in the United States. It also leases and sells mobile homes and mobile home parks, as well as offers an alternative to traditional housing. The company provides tax resolution bookkeeping, and tax preparation service to individuals and companies that have federal and state tax liabilities. It also engages in the commercial real estate property business. The company was formerly known as Cardiff International, Inc. and changed its name to Cardiff Lexington Corporation in January 2018. Cardiff Lexington Corporation was incorporated in 2001 and is headquartered in Fort Lauderdale, Florida.

Sector

Financial Services

Industry

Asset Management

Employees

IPO Date

2005-12-22

Beta

2.47

Websitewww.cardifflexington.com↗